日本ケミファ(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|---|---|---|
東証STD | 医薬品 | 4539/E00957 | NIPPON CHEMIPHAR CO., LTD. |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|---|---|---|---|---|---|---|---|---|
2022/08/26 | 日証協 | 50,565株 | -0.89% | 10,747株 | -10.84% | 81,620株 | +4.21% | 6,205株 | -40.62% |
2022/08/19 | 日証協 | 51,017株 | -0.87% | 12,054株 | -56.64% | 78,321株 | -0.38% | 10,449株 | +197.69% |
2022/08/12 | 日証協 | 51,464株 | +0.98% | 27,801株 | -52.9% | 78,622株 | +3.31% | 3,510株 | -74.79% |
2022/08/05 | 日証協 | 50,964株 | +22.39% | 59,026株 | +121.89% | 76,102株 | +14.27% | 13,925株 | +25.26% |
2022/07/29 | 日証協 | 41,640株 | +14.27% | 26,601株 | +40.75% | 66,596株 | +11.37% | 11,117株 | +329.73% |
2022/07/22 | 日証協 | 36,440株 | -0.72% | 18,900株 | -10.66% | 59,796株 | +0.65% | 2,587株 | -62.51% |
2022/07/15 | 日証協 | 36,706株 | -0.18% | 21,154株 | +65.87% | 59,409株 | +1.54% | 6,901株 | +43.68% |
2022/07/08 | 日証協 | 36,774株 | +6.36% | 12,753株 | -39.99% | 58,509株 | +0.53% | 4,803株 | -60.28% |
2022/07/01 | 日証協 | 34,574株 | +42.74% | 21,253株 | -18.26% | 58,202株 | +20.75% | 12,091株 | -18.39% |
2022/06/24 | 日証協 | 24,221株 | +11% | 26,000株 | +108% | 48,202株 | +8.07% | 14,816株 | +141.62% |
2022/06/17 | 日証協 | 21,821株 | +13.47% | 12,500株 | +166.13% | 44,602株 | +1.6% | 6,132株 | +1265.7% |
2022/06/10 | 日証協 | 19,230株 | -3.74% | 4,697株 | -70.51% | 43,900株 | -6% | 449株 | -95.92% |
2022/06/03 | 日証協 | 19,977株 | +78.94% | 15,925株 | +1003.6% | 46,700株 | +13.66% | 11,000株 | +181.26% |
2022/05/27 | 日証協 | 11,164株 | +3.41% | 1,443株 | -61% | 41,088株 | +1.76% | 3,911株 | -31.97% |
2022/05/20 | 日証協 | 10,796株 | +14.9% | 3,700株 | -22.92% | 40,379株 | +6.04% | 5,749株 | -34.16% |
2022/05/13 | 日証協 | 9,396株 | +25.35% | 4,800株 | +1100% | 38,080株 | +13.57% | 8,732株 | +853.28% |
2022/05/06 | 日証協 | 7,496株 | -2.6% | 400株 | -63.64% | 33,529株 | +4.36% | 916株 | -83.28% |
2022/04/28 | 日証協 | 7,696株 | +14.93% | 1,100株 | +175% | 32,128株 | +8.08% | 5,480株 | +107.97% |
2022/04/22 | 日証協 | 6,696株 | +3.08% | 400株 | +300% | 29,725株 | +4.94% | 2,635株 | +285.23% |
※株式分割は考慮していませんのでご注意ください。